LMCG Investments’s Novartis NVS Stock Holding History

LMCG Investments’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$7.53M	Hold	91,475	–	–	0.16%	246
2015 Q2	$8.06M	Hold	91,475	–	–	0.17%	233
2015 Q1	$8.08M	Sell	91,475 -154	-0.2%	-$13.7K	0.17%	242
2014 Q4	$7.61M	Sell	91,629 -251	-0.3%	-$20.8K	0.17%	231
2014 Q3	$7.75M	Buy	91,880 +304	+0.3%	+$24.6K	0.17%	229
2014 Q2	$7.43M	Buy	91,576 +181	+0.2%	+$14.2K	0.16%	242
2014 Q1	$6.96M	Buy	91,395 +223	+0.2%	+$16.3K	0.15%	240
2013 Q4	$6.57M	Hold	91,172	–	–	0.14%	239
2013 Q3	$6.27M	Hold	91,172	–	–	0.15%	230
2013 Q2	$5.78M	Buy	+91,172	New	+$5.93M	0.15%	223

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Institutional Capital Chicago, Illinois $6.75B AUM 3.51% 1-Year Est. Return

LMCG Investments's NVS Position: Q3 2015 in Review

LMCG Investments held its Novartis (NVS) position steady in Q3 2015 at 91,475 shares worth $7.53M. The position accounts for 0.16% of the portfolio, ranked #246.

LMCG Investments first reported a position in NVS in Q2 2013 and has held it in 10 quarters since. The position peaked at $8.08M in Q1 2015. 926 funds tracked by Wall St. Rank hold NVS as of Q3 2015.

LMCG Investments held 91,475 shares of Novartis worth $7.53M as of Q3 2015.
LMCG Investments left its Novartis share count unchanged in Q3 2015.
Novartis made up 0.16% of LMCG Investments's portfolio in Q3 2015, its #246 holding.
LMCG Investments first reported a position in Novartis in Q2 2013 and has held it in 10 quarters since.
LMCG Investments's Novartis position peaked at $8.08M in Q1 2015.
926 funds tracked by Wall St. Rank held Novartis as of Q3 2015.

Based on LMCG Investments's 13F filing for Q3 2015, filed 4 Nov 2015.